Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3704-3709, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
In Vivo Administration of Mycobacterial Cord Factor
(Trehalose 6,6'-Dimycolate) Can Induce Lung and Liver Granulomas and
Thymic Atrophy in Rabbits
Naoko
Hamasaki,1,2,*
Ko-Ichi
Isowa,3
Kohachi
Kamada,3
Yoshitake
Terano,4
Takayuki
Matsumoto,2
Tetsuo
Arakawa,2
Kazuo
Kobayashi,1 and
Ikuya
Yano1
Departments of Host
Defense1 and
Gastroenterology,2 Osaka City
University Graduate School of Medicine, Abeno-ku, Osaka 545-8585, Toneyama Institute for Tuberculosis Research, Toyonaka,
Osaka 560-0045,4 and The Center of
Japan Biological Chemistry, Kaizu-gunn, Gifu
503-0628,3 Japan
Received 11 October 1999/Returned for modification 25 November
1999/Accepted 15 February 2000
 |
ABSTRACT |
Trehalose 6,6'-dimycolate (TDM) is a cell surface molecule of
Mycobacterium tuberculosis. TDM induced a loss of body
weight and prominent granulomas in the liver and lungs by the
intravenous injection of TDM into rabbits. TDM also induced atrophy of
the thymus and spleen due to apoptosis. By contrast, sulfolipid
(2,3,6,6'-tetraacyl trehalose 2'-sulfate) induced neither toxicity, nor
granuloma formation, nor atrophy of the thymus and spleen. In rabbits
the histopathological changes were more dramatic than in mice. The rabbit model may be more sensitive and may provide more information on
the beneficial or pathological effects of TDM.
 |
TEXT |
Tuberculosis has recently been
reemerging, owing to human immunodeficiency virus infection,
overcrowded populations, poverty, and the appearance of drug-resistant
mycobacteria. Granuloma formation followed by caseous necrosis,
liquefaction, and subsequent cavity formation are central processes in
the pathology of human pulmonary tuberculosis, and these changes are
induced by cell-mediated immune responses to mycobacterial infection
(4, 16, 17). However, precise mechanisms and processes for
the development of tuberculosis have not been fully clarified,
particularly concerning the role of each cellular component or product
of Mycobacterium tuberculosis at the molecular level. Among
mycobacterial components, only trehalose 6,6'-dimycolate (TDM) can
induce granulomatous lesions in experimental animals without protein
antigen. To explore the role of delayed-type hypersensitivity to
mycobacterial antigens, most immunologic studies of tuberculosis have
been carried out using mice and guinea pigs (4).
Mice cannot develop cavitary lesions induced by tuberculosis. It has
been reported that granulomatous changes in rabbit lungs are followed
by caseous necrosis, liquefaction, and finally cavity formation by
direct intrapulmonary injection of live or heat-killed bacilli or their
components, including lipoprotein antigen and glycolipid (12, 14,
22). In the process, hydrolytic enzymes, including nucleases,
proteinases, and cathepsin D from activated macrophages, participate in
liquefaction and cavity formation (3-6). Using mouse models, we
previously demonstrated granuloma- and cytokine-inducing activities of
mycolyl glycolipids such as TDM (10, 15, 18, 20, 23). In
mice, TDM and related mycolyl glycolipids (glucose mycolate or
trehalose monomycolate) can induce foreign-body-type granulomas in the
absence of protein antigens, although TDM cannot induce further
pathological changes, even in hyperimmune mice. The rabbit is the only
animal that readily produces tuberculous cavities (3, 22).
Furthermore, tuberculosis in rabbits resembles human disease more
closely than does tuberculosis in any other animal species (4,
13). The present study is the first report describing granuloma
formation in rabbits that has been induced by the intravenous
administration of protein-free TDM and the absence of granulomas with
related glycolipids such as sulfolipid (SL; 2,3,6,6'-tetraacyltrehalose
2'-sulfate), another virulence factor of M. tuberculosis.
Rabbits.
Specific-pathogen-free New Zealand White female
rabbits, 8 weeks old (average body weight, 1.7 kg), were purchased from
Japan KEARI Co. (Gifu, Japan).
Preparation of TDM and SL.
TDM and SL were extracted from the
total lipid of heat-killed M. tuberculosis AOYAMA-B. Each
glycolipid was finally separated by preparative thin-layer
chromatography of silica gel (Uniplate; 20 by 20 cm, 250 µm;
Analtech, Inc., Newark, Del.). The purity of glycolipid was
confirmed by fast atom bombardment mass spectrometry of
the intact molecule with a JMSSX102A double-focusing mass
spectrometer (JEOL, Tokyo, Japan) before and after hydrolysis of the
cord factor. The result showed that the only hydrolysis products were
-, methoxy-, and keto-mycolic acids and trehalose (7).
In vivo administration of water-oil-water (w/o/w) emulsion of
glycolipids.
Purified TDM or SL was emulsified with 0.2% Tween 80 and 3.2% Freund's incomplete adjuvant (Difco, Detroit, Mich.) in 0.1 M phosphate-buffered saline to form w/o/w emulsion (18, 20). As controls, w/o/w emulsion micelles without glycolipids were used.
Rabbits were injected intravenously with various doses of TDM or SL in
the form of a w/o/w emulsion. Rabbits were sacrificed on day 2, 7, or
21 after the injection. For organ index determinations, lungs, liver,
spleen, and thymus were removed. The organ index was calculated as the
organ weight (in grams)/body weight (in grams) × 100. For
histological examination, organs were fixed in 10% formalin and
embedded in paraffin. Sections were stained with hematoxylin and eosin (HE).
Histopathological examination.
To detect apoptotic
changes, sections of the spleen and thymus were stained by TUNEL
(terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick
end labeling) (TACSTM In Situ Apoptosis Detection Kit; Trevigen, Inc.,
Gaithersburg, Md.).
Statistical analysis.
Data were analyzed by using Statview 5.0 (SAS Institute, Inc., Cary, N.C.) and expressed as the mean ± the
standard deviation (SD). Data that appeared to be statistically
significant were compared by an analysis of variance designed for
comparing the means of multiple groups and then considered significant
if the P values were <0.05.
Toxicity of TDM and SL.
TDM induces a lethal toxicity in mice,
when injected intravenously in w/o/w emulsion micelles (2).
Intravenous injection of TDM into rabbits resulted in diarrhea and
delay in the body weight increase in a dose-dependent fashion. Lethal
toxicity was not observed in the rabbits administered a dose of 20 mg
of TDM until 21 days after the challenge. The toxic effect on the
rabbit body weight continued at least for 21 days after a single
injection of TDM (Fig. 1). Administration
of vehicle micelles served as a control, and SL induced neither lethal
toxicity nor a delay in the increase in rabbit body weights.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Time-dependent changes in body weight in rabbits
challenged with either TDM or SL derived from M. tuberculosis AOYAMA-B. The data represent the mean ± the SD
compiled from experiments with three to nine rabbits per condition.
*, significant difference (P < 0.05) compared to the
SL or control (CTRL) group.
|
|
Induction of granuloma formation.
TDM induces
foreign-body-type granulomas in mice by intravenous injection of w/o/w
emulsion micelles (1). Intravenous injection of 3 to 20 mg
of TDM per rabbit induced maximal granulomatous lesions in lungs 7 days
after the injection. More than threefold increases in the lung weight
and index were observed in a dose-dependent manner (Fig.
2). The lung weight and index returned to
baseline levels 21 days after injection (Fig.
3). Grossly, lungs were enlarged and
showed marked white granular surfaces, which in some parts fused with
each other to form large and tightly infiltrated granulomas entirely in
groups of rabbits given 10 to 20 mg of TDM. The weight of the liver and
the liver index were not changed or rather decreased slightly for 7 to
21 days after injection of TDM, although small granulomas were clearly
observed grossly 7 days after the injection. SL, however, did not
induce significant granulomas in lungs and liver at 7 to 21 days after
the challenge. Administration of w/o/w emulsion alone did not result in
any significant changes in organ indices.

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 2.
Dose-related changes in organ indices of rabbits 7 days
after the challenge with either TDM or SL. A more than threefold
increase in the lung index was observed in rabbits given TDM. SL did
not have any effect. Following the administration of TDM, thymic and
splenic weights decreased to one-half of those of the controls. The
data indicate the mean ± the SD compiled from experiments with
three to nine rabbits per condition. Asterisks indicate a significant
difference (*, P < 0.05; **, P < 0.01) compared to the SL or control (CTRL) group.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 3.
Time-related changes in organ indices of rabbits 2, 7, and 21 days after the injection with TDM or SL. The lung index and the
atrophy of the thymus reached a peak at day 7 in rabbits given TDM. SL
did not produce any changes. The data represent the mean ± the SD
compiled from experiments with three to nine rabbits per condition. *,
a significant difference (P < 0.05) compared to the SL
or control (CTRL) group.
|
|
Induction of thymic and splenic atrophy.
TDM induces
remarkable atrophy of the thymus in mice due to apoptosis when injected
intravenously in w/o/w emulsion micelles (18). Intravenous
injection of TDM into rabbits induced peak atrophy of both the thymus
and the spleen by day 7. The weights of the thymus and spleen were
reduced to one-half or less of those of the controls (Fig. 2). Atrophy
of the thymus and spleen was dose responsive, and organ weights reached
a minimum on day 7 after the injection and returned to the control
level on day 21, paralleled by the lung granuloma formation and
resolution (Fig. 3). Administration of emulsion without glycolipids or
with SL showed neither atrophy nor a decrease in the organ weight of
the rabbit thymus or spleen.
Histopathological changes.
Histological changes were observed
distinctively in the lungs, liver, thymus, and spleen 7 days after
injection of TDM. In rabbits given 20 mg of TDM, the lungs showed
solidification due to the loss of normal alveolar structure. Numerous
lightly stained mature epithelioid cells and lymphocytes with fewer
neutrophils infiltrated into the alveolar space to form well-organized
granulomas, although no distinctive caseation and necrosis were
observed (Fig. 4). Multinucleated giant
cells could be observed occasionally. Scattered areas of pneumonia and
perivasculitis were also seen in the lungs. SL did not induce
granulomas in the lungs and liver, although focal pneumonia, mild
perivasculitis, and slight macrophage infiltration were found. In the
livers of rabbits injected with 10 to 20 mg of TDM, significant
granuloma formation was observed (Fig. 4). These granulomas were
solitary but highly organized and islet-like. In the livers of rabbits
injected with 20 mg of TDM, foreign-body-type multinucleated giant
cells and lymphocyte infiltration were observed mostly in the marginal
region of granulomatous lesions. It was particularly noted that in the
central region of liver granulomas, significant focal necrosis of
hepatocytes was observed, suggesting that a large amount of TDM
administration might induce liver damage due to its potent toxicity
(11). In thymus tissues of rabbits injected with 10 to 20 mg
of TDM, apoptotic nuclei or nuclear condensation was observed by HE and
TUNEL staining (Fig. 5). Electron
microscopically marked nuclear condensation and karyorrhectic changes
in thymic cortical lymphocytes were observed (data not shown). In the
spleens of rabbits given 10 to 20 mg of TDM, both granulomatous and
apoptotic changes were observed in the white pulp. In addition,
follicular hyperplasia and splenitis were observed in rabbits injected
with TDM. Follicle formation, indicating the development of humoral
immunity, was also observed in the spleens of TDM-injected rabbits. SL
did not induce any significant changes such as apoptosis in the thymus and spleen (Table 1). Granulomatous
changes in lungs and livers continued up to 21 days after the
challenge, but the size and number of lung granulomas decreased
significantly. By contrast, rabbits given SL did not show significant
granulomatous changes in lungs and livers on days 7 to 21. The
apoptotic changes in the thymus and spleen elicited by administration
of TDM disappeared by day 21; however, granulomas of the spleen and
splenitis induced by TDM or SL (10 mg) continued for a longer period of
time.

View larger version (134K):
[in this window]
[in a new window]
|
FIG. 4.
Histopathology of lung and liver granulomas in a rabbit
challenged with TDM or SL (HE stain). The rabbit was sacrificed 7 days
after the challenge with 20 mg of TDM. In the lung, alveolar spaces
were fully replaced with granulomatous lesions (>90% of alveolar
space area), and the normal alveolar structure disappeared. The
development of lung granulomas was dose responsive. Typical granulomas
induced by TDM were characteristic in that they consisted of large
macrophages with lightly stained round nuclei (epithelioid cells)
infiltrated into the central region with lymphocytes with densely
stained nuclei in the marginal region. In the livers of rabbits given
20 mg of TDM, solitary granulomas with occasional multinucleated giant
cells were seen. The number of solitary granulomas was dependent on the
dose of TDM injected. In the central region, macrophages, epithelioid
cells, and hepatocytes were stained lightly, and their nuclei could
hardly be seen, a result probably due to necrosis or apoptosis.
Lymphocytes infiltrated into the marginal region of granulomas were
observed.
|
|

View larger version (197K):
[in this window]
[in a new window]
|
FIG. 5.
Apoptosis of thymocytes and splenocytes in rabbits
challenged with SL or TDM (TUNEL stain). Rabbits were sacrificed 7 days
after the challenge. Cortical lymphocytes were decreased, and apoptosis
was noted in the thymus of a rabbit given TDM. Foci of apoptotic
lymphocytes could be seen in the white pulp of the spleen from a rabbit
challenged with TDM.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Histopathological findings in New Zealand White rabbits
given a single intravenous administration of glycolipids from
M. tuberculosis AOYAMA-Ba
|
|
TDM is a toxic substance in mice, although it possesses potent adjuvant
activity by stimulating cell-mediated immunity with
coadministration of
protein antigen (
19). This adjuvant activity
and
granulomatogenic activity can be further potentiated by costimulation
with other cellular components, such as cell wall skeleton derived
from
tubercle bacilli (
19). Because mycobacterial TDM showed
a
potent toxicity and marked granuloma-inducing activity in rabbits,
these highly organized granulomatous lesions may play an important
role
in bactericidal activity. On the other hand, since mycobacterial
TDM
has been reported to be toxic in mice due to the inhibition
of liver
mitochondrial electron transport systems (
11), such
a toxic
effect may play a role in the liver damage in rabbits.
At present, it
is difficult to conclude whether such toxic effects
induce tissue
necrosis directly or indirectly, and we need more
precise and
immunological observation of histological changes
of granulomatous
tissues after TDM
administration.
Thymic atrophy induced by TDM was closely related to granuloma
formation in mice (
18). Because thymectomized mice fail to
develop
Mycobacterium bovis BCG cell wall-induced lung
granulomas
but restore their capacity to respond after the transfer of
thymic
or splenic cells, thymocytes appeared to be necessary for
T-cell-mediated
granulomatous responses in mice (
9).
TDM-induced granulomas
in rabbits were also paralleled by marked
atrophy of the thymus
and spleen, suggesting that thymus or T
lymphocytes may play an
important role in the development of lung
granulomas. SL did not
induce granuloma formation or cause thymic and
splenic atrophy.
Although TDM and SL possess a common structure in
having a trehalose
moiety, the different biological effects of these
two compounds
observed here must be derived from the differences in the
fatty
acid moieties (
8). Such cell surface molecules make
contact
with host cells and stimulate them at the early stage of the
infection.
Mycobacterial TDM may contact a larger part of the host cell
surface
than SL does, thus causing extensive stimulation of host
cells.
The exact physiological role of apoptosis induced by TDM must be
clarified. The thymic and splenic atrophy produced by TDM
could result
in the negative selection, involving activation-induced
T-cell death,
before the specific cellular immunity against
M. tuberculosis antigen develops. We have reported previously that
abundant NK cells and extrathymic T lymphocytes are found in lung
granulomas induced by TDM challenge in mice (
20). The
biological
effect of TDM is a double-edged sword in tuberculosis. TDM
shows
granuloma-inducing activity, a benefit associated with gamma
interferon
production and intracellular killing (
21). In
contrast, TDM
shows detrimental functions such as lethal toxicity, loss
of body
weight, liver damage, and temporal immunosuppression in mice
and
rabbits. Probably, the balance of these two potentials determines
whether the disease progresses or
regresses.
The challenge for the future will be to understand and clarify the
precise role of TDM in the pathophysiology of mycobacterial
infections
in rabbits. Such an understanding may open new avenues
for better
interventions against tuberculosis in rabbits as well
as
humans.
 |
ACKNOWLEDGMENTS |
We thank Tetsuo Kuroki for helpful suggestions.
This work was supported by grants of Research on Emerging and
Re-emerging Infectious Diseases (Health Sciences Research Grants, Ministry of Health and Welfare) and The United States-Japan Cooperative Medical Science Program against Tuberculosis and Leprosy.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Host Defense, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. Phone: 81-6-6645-3746. Fax: 81-6-6645-3747. E-mail:
naoko{at}med.osaka-cu.ac.jp.
Editor:
S. H. E. Kaufmann
 |
REFERENCES |
| 1.
|
Bekierkunst, A.,
I. S. Levij,
E. Yarkoni,
E. Vilkas,
A. Adam, and E. Lederer.
1969.
Granuloma formation induced in mice by chemically defined mycobacterial fractions.
J. Bacteriol.
100:95-102[Abstract/Free Full Text].
|
| 2.
|
Bloch, H.
1950.
Studies on the virulence of tubercle bacilli. Isolation and biological properties of a constituent of virulent organisms.
J. Exp. Med.
91:197-219[Abstract].
|
| 3.
|
Converse, P. J.,
A. M. Dannenberg, Jr.,
J. E. Estep,
K. Sugisaki,
Y. Abe,
B. H. Schofield, and M. L. M. Pitt.
1996.
Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli.
Infect. Immun.
64:4776-4787[Abstract].
|
| 4.
|
Dannenberg, A. M., Jr.
1991.
Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis.
Immunol. Today
12:228-233[CrossRef][Medline].
|
| 5.
|
Dannenberg, A. M., Jr.
1993.
Immunopathogenesis of pulmonary tuberculosis.
Hosp. Pract.
15:51-58.
|
| 6.
|
Dannenberg, A. M., Jr.
1994.
Rabbit model of tuberculosis, p. 149-156.
In
B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection, and control. ASM Press, Washington, D.C.
|
| 7.
|
Fujiwara, N.,
J. Pan,
K. Enomoto,
Y. Terano,
T. Honda, and I. Yano.
1999.
Production and partial characterization of anti-cord factor (trehalose-6,6'-dimycolate) IgG antibody in rabbits recognizing mycolic acid subclass of Mycobacterium tuberculosis or Mycobacterium avium.
FEMS Immunol. Med. Microbiol.
24:141-149[Medline].
|
| 8.
|
Goren, M. B.,
O. Brokl, and B. C. Das.
1976.
Sulfatides of Mycobacterium tuberculosis: the structure of the principal sulfatide (SL-1).
Biochemistry
15:2728-2735[CrossRef][Medline].
|
| 9.
|
Kakimura, M.,
K. Onoe,
M. Okada,
T. Kimura,
K. Kato,
H. Okuyama,
K. Morikawa, and K. Yamamoto.
1981.
Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine.
Immunology
43:1-9[Medline].
|
| 10.
|
Kaneda, K.,
Y. Sumi,
F. Kurano,
Y. Kato, and I. Yano.
1986.
Granuloma formation and hemopoiesis induced by C36-48-mycolic acid-containing glycolipids from Nocardia rubra.
Infect. Immun.
54:869-875[Abstract/Free Full Text].
|
| 11.
|
Kato, M.
1968.
Studies of a biochemical lesion in experimental tuberculosis in mice. VIII. Structural and functional damage in mouse liver mitochondria under the toxic action of cord factor.
Am. Rev. Respir. Dis.
98:260-269[Medline].
|
| 12.
|
Lurie, M. B.
1932.
The correlation between the histological changes and the fate of living tubercle bacilli in the organs of tuberculous rabbits.
J. Exp. Med.
55:31-54[Abstract].
|
| 13.
|
Lurie, M. B.
1964.
Resistance to tuberculosis: experimental studies in native and acquired defensive mechanisms.
Harvard University Press, Cambridge, Mass.
|
| 14.
|
Maeda, H.,
Y. Yamamura, and Y. Ogawa.
1977.
Mycobacterial antigens relating to experimental pulmonary cavity formation.
Am. Rev. Respir. Dis.
115:617-623[Medline].
|
| 15.
|
Matsunaga, I.,
S. Oka,
N. Fujiwara, and I. Yano.
1996.
Relationship between induction of macrophage chemotactic factors and formation of granulomas caused by mycolyl glycolipids from Rhodococcus ruber (Nocardia rubra).
J. Biochem.
120:663-670[Abstract/Free Full Text].
|
| 16.
|
Myrvik, Q. N.
1982.
Immunopathology of pulmonary tuberculosis.
Adv. Exp. Med. Biol.
155:649-657[Medline].
|
| 17.
|
Myrvik, Q. N.,
E. S. Leake, and K. Tenner-Racz.
1983.
Interaction of mycobacteria with normal and immunologically activated alveolar macrophages.
Adv. Exp. Med. Biol.
162:83-98[Medline].
|
| 18.
|
Ozeki, Y.,
K. Kaneda,
N. Fujiwara,
M. Morimoto,
S. Oka, and I. Yano.
1997.
In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6'-dimycolate).
Infect. Immun.
65:1793-1799[Abstract].
|
| 19.
|
Ribi, E.,
D. L. Granger,
K. C. Milner,
K. Yamamoto,
S. M. Strain,
R. Parker,
R. W. Smith,
W. Brehmer, and I. Azuma.
1982.
Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials.
Immunology
46:297-305[Medline].
|
| 20.
|
Tabata, T.,
K. Kaneda,
H. Watanabe,
T. Abo, and I. Yano.
1996.
Kinetics of organ-associated natural killer cells and intermediate CD3 cells during pulmonary and hepatic granulomatous inflammation induced by mycobacterial cord factor.
Microbiol. Immunol.
40:651-658[Medline].
|
| 21.
|
Watanabe, K.,
R. Hasunuma,
T. Horikoshi,
H. Yamana,
H. Maruyama,
N. Fujiwara,
Y. Kumazawa, and I. Yano.
1999.
Induction of hypersensitivity to endotoxin lethality in mice by treatment with trehalose 6,6'-dimycolate but not with 2,3,6,6'-tetraacyl trehalose 2'-sulfate.
J. Endotoxin Res.
5:23-30.
|
| 22.
|
Yamamura, Y.,
H. Maeda, and Y. Ogawa.
1986.
Experimental pulmonary cavity formation by mycobacterial components and synthetic adjuvants.
Microbiol. Immunol.
30:1175-1187[Medline].
|
| 23.
|
Yano, I.,
I. Tomiyasu,
S. Kitabatake, and K. Kaneda.
1984.
Granuloma forming activity of mycolic acid-containing glycolipids in Nocardia and related taxa.
Acta Leprol.
2:341-349[Medline].
|
Infection and Immunity, June 2000, p. 3704-3709, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Woodruff, P. J., Carlson, B. L., Siridechadilok, B., Pratt, M. R., Senaratne, R. H., Mougous, J. D., Riley, L. W., Williams, S. J., Bertozzi, C. R.
(2004). Trehalose Is Required for Growth of Mycobacterium smegmatis. J. Biol. Chem.
279: 28835-28843
[Abstract]
[Full Text]
-
Holten-Andersen, L., Doherty, T. M., Korsholm, K. S., Andersen, P.
(2004). Combination of the Cationic Surfactant Dimethyl Dioctadecyl Ammonium Bromide and Synthetic Mycobacterial Cord Factor as an Efficient Adjuvant for Tuberculosis Subunit Vaccines. Infect. Immun.
72: 1608-1617
[Abstract]
[Full Text]
-
Indrigo, J., Hunter, R. L. Jr, Actor, J. K.
(2003). Cord factor trehalose 6,6'-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology
149: 2049-2059
[Abstract]
[Full Text]
-
Indrigo, J., Hunter, R. L. Jr, Actor, J. K.
(2002). Influence of trehalose 6,6'-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology
148: 1991-1998
[Abstract]
[Full Text]
-
Yamagami, H., Matsumoto, T., Fujiwara, N., Arakawa, T., Kaneda, K., Yano, I., Kobayashi, K.
(2001). Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Foreign-Body- and Hypersensitivity-Type Granulomas in Mice. Infect. Immun.
69: 810-815
[Abstract]
[Full Text]
-
Saita, N., Fujiwara, N., Yano, I., Soejima, K., Kobayashi, K.
(2000). Trehalose 6,6'-Dimycolate (Cord Factor) of Mycobacterium tuberculosis Induces Corneal Angiogenesis in Rats. Infect. Immun.
68: 5991-5997
[Abstract]
[Full Text]